Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.030 | 1.000 | 3 | 2015 | 2016 | ||||||
Colorectal Carcinoma
|
1962 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 0.500 | 2 | 2015 | 2018 | ||||||
Liver carcinoma
|
942 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 1.000 | 2 | 2009 | 2014 | ||||||
Malignant neoplasm of stomach
|
615 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Malignant Neoplasms
|
1641 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||
Squamous cell carcinoma of oropharynx
|
33 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
Stomach Carcinoma
|
652 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Breast Carcinoma
|
2793 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinogenesis
|
355 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Cervical Squamous Cell Carcinoma
|
44 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Cervix carcinoma
|
283 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Degenerative polyarthritis
|
247 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Endometrial Carcinoma
|
326 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Endometriosis
|
274 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Epithelial ovarian cancer
|
129 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Hepatitis B
|
519 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1 | 2014 | 2014 | |||||||
Ischemic stroke
|
704 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant neoplasm of breast
|
3417 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of endometrium
|
197 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Nasopharyngeal carcinoma
|
320 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Papillary thyroid carcinoma
|
204 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Primary malignant neoplasm
|
1374 | 0.667 | 0.480 | 2 | 112774138 | 3 prime UTR variant | -/TGAA | delins | 0.010 | 1.000 | 1 | 2019 | 2019 |